Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Resected Pancreatic Adenocarcinoma
Birmingham
Resected Pancreatic Adenocarcinoma Clinical Trials in Birmingham
1 recruiting
Birmingham, United Kingdom
Showing
1–1
of
1
trials
Recruiting
Phase 3
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Pancreatic Cancer
PDAC
PDAC - Pancreatic Ductal Adenocarcinoma
+2 more
Revolution Medicines, Inc.
500 enrolled
17 locations
NCT07252232
Feedback